MIPL-Logo

 

MIRA INFORM REPORT

 

 

Report No. :

332351

Report Date :

18.07.2015

 

IDENTIFICATION DETAILS

 

Name :

CAPLIN POINT LABORATORIES LIMITED

 

 

Registered Office :

“Narbavi”, No.3, Lakshmanan Street, T. Nagar, Chennai – 600 017, Tamil Nadu

Tel. No.:

91-44-28156653/ 28156905

 

 

Country :

India

 

 

Financials (as on) :

30.06.2014

 

 

Date of Incorporation :

16.04.1990

 

 

Com. Reg. No.:

18-019053

 

 

Capital Investment / Paid-up Capital :

Rs. 151.100 Million

 

 

CIN No.:

[Company Identification No.]

L24231TN1990PLC019053

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturing of Pharmaceuticals Formations.

 

 

No. of Employees :

Not Divulged [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (68)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 1700000

 

 

Status :

Goods

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is well - established company having fine track record.

 

The rating reflects company’s healthy financial risk profile marked by adequate net worth base and decent profitability margins of the company.

 

Trade relations are reported are reported as fair. Business is active. Payment are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

INFORMATION DENIED BY

 

Name :

Mr. Ganapati Subramaniam 

Designation :

Finance Head

Contact No.:

91-44-45929100

Date :

14.07.2015

 

 

 

LOCATIONS

 

Registered Office/Corporate office :

“Narbavi”, No.03, Lakshmanan Street, T. Nagar, Chennai – 600 017, Tamil Nadu, India

Tel. No.:

91-44-28156653/ 28156905

Fax No.:

91-44-28154952

E-Mail :

md-secreatary@dishnetdsl.net

admin@caplinpoint.net

exports-1@dishnetdsl.net

exports@caplinpoint.net

tricap@mds.vsnl.net

info@caplinpoint.net

investor@caplinpoint.net

Website :

www.caplinpoint.net

 

 

FACTORY

 

 

 

Unit 1:

R.S. No.85/3, Suthukeny Village, Katterikuppm (Post), Mannadipet Commune  Panchyat, Pondicherry 605502, India.

Tel. No.:

91-413-2674402 / 2674137

Fax No.:

91-413-2674002

E-Mail :

caplinpoint@gmail.com

production@caplinpoint.net

caplin@satyam.net.in

 

 

Unit 2:

Khasra No. 435, Village Suraj Majra, N.H.No. 21, Baddi, Teh Nalagarh, Dist Solan, Himachal Pradesh – 173205, India

E-Mail :

livingston@caplinpoint.net

 

 

Unit 3:

Guruvarajakandigai, Sirupuzhalpettai (Post), Gummidipoondi Taluka, Thiruvallur District, Tamil Nadu – 601 201, India

 

 

Research and Development Unit :

19, Chinnapuliyur Village, Gummidipoondi, Thiruvallur District, Tamilnadu, India.

Tel. No.:

91-44-27940274 / 65311262

Fax No.:

91-44-27940274

E-Mail :

mayindlab@vsnl.net

 

 

DIRECTORS

 

As on 30.06.2014

 

Name :

Mr. C.C. Paarthipan

Designation :

Chairman

 

 

Name :

Mr. M. Jayapal

Designation :

Managing Director

 

 

Name :

Mr. D. P. Mishra

Designation :

Whole Time Director

 

 

Name :

Dr. Sridhar Ganesan

Designation :

Whole Time Director

 

 

Name :

Mr. P.T. Baby Thomas

Designation :

Independent Director

 

 

Name :

Mr. V. Thirumalai

Designation :

Independent Director

 

 

Name :

Mr. Venkat Radhakrishnan

Designation :

Independent Director

 

 

Name :

Dr. R. Ravichandran

Designation :

Additional Director / Independent Director

 

 

Name :

Dr. KC John

Designation :

Additional Director / Independent Director

 

 

Name :

Mr. R Vijay Venkatramaan 

Designation :

Independent Director

 

 

EXECUTIVE DIRECTOR :

 

Name :

Mr. M. Jayapal

Designation :

Managing Director

 

 

Name :

Mr. D.P. Mishra

Designation :

Whole Time Director

 

 

Name :

Dr. Sridhar Ganesan

Designation :

Whole Time Director

 

 

KEY EXECUTIVES

 

Name :

Mr. S. Mihan Raj

Designation :

Secretary/ Chief Financial officer

 

 

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.06.2015

 

Category of Shareholder

Total No. of Shares

Total shareholding as a % of Total No.

 

 

 

(A) Shareholding of Promoter and Promoter Group

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

10015353

66.28

http://www.bseindia.com/include/images/clear.gifBodies Corporate

231400

1.53

http://www.bseindia.com/include/images/clear.gifSub Total

10246753

67.81

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

10246753

67.81

(B) Public Shareholding

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

11700

0.08

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

6227

0.04

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

256501

1.70

http://www.bseindia.com/include/images/clear.gifSub Total

274428

1.82

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

283452

1.88

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

2756213

18.24

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

1300738

8.61

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

248416

1.64

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

190777

1.26

http://www.bseindia.com/include/images/clear.gifClearing Members

12139

0.08

http://www.bseindia.com/include/images/clear.gifOverseas Corporate Bodies

45500

0.30

http://www.bseindia.com/include/images/clear.gifSub Total

4588819

30.37

Total Public shareholding (B)

4863247

32.19

Total (A)+(B)

15110000

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

15110000

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Pharmaceuticals Formations.

 

 

Products :

Not Available

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

Not Divulged [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

Bankers :

Bank Name

Not Divulged

Branch

Not Divulged

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Facilities :

(Rs. In Million)

SECURED LOAN

As on

30.06.2014

As on

30.06.2014

LONG TERM BORROWING

 

 

Term Loan from Bank

28.123

39.258

From Others

3.865

6.652

Less: Current Maturities of long term debt

(11.760)

(11.396)

SHORT TERM BORROWING

 

 

Loans repayable on demand - From Bank

0.500

0.530

 

 

 

Total

20.728

35.044

 

Auditors :

 

Name :

CNGSN and Associates LLP

Chartered Accountants

Address :

No. 43, (Old No.22), Swathi Court, Flat No. C and D, Vijayaraghava Road, T. Nagar, Chennai - 600017, Tamilnadu, India

Tel. No.:

91-44-45541480/81

Fax No.:

91-44-45541482

E-Mail :

info@cngsn.com

Website:

www.cngsn.com

 

 

Statutory Auditors:

 

Name :

M Raghunath and Company

Chartered Accountants

Address :

New No. 22 (Old No. 83/2), Millers Road, Kilpauk, Chennai - 600 010, Tamilnadu, India

 

 

Cost Auditors:

G. Thangaraj

Chartered Accountant

 

12B, Block 3, F2, Behind Venkatesha Nilayam, Jayalakshmipuram Main Road, Nungambakkam, Chennai 600 034, Tamilnadu, India

 

 

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Related Parties  :

  • Argus Salud Pharma LLP

 

 

 

 

CAPITAL STRUCTURE

 

As on 30.06.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

17000000

Equity Shares

Rs.10/- each

Rs. 170.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15110000

Equity Shares

Rs.10/- each

Rs. 151.100 Million

 

 

 

 

 

a) Reconciliation of number of equity shares outstanding at the beginning and at the end of the year

 

Particular

As at 30.06.2014

Number of shares outstanding at the beginning of the year

15110000

Add: Number of share allotted as fully paid up during the year

-

Less: Number of share bought back during the year

-

Number of share outstanding at the end of the year

15110000

 

b)  Rights, preference and restrictions attached to shares

      Equity Shares

 

The Company has only one class of equity share having a par value of 10/- per share. Each shareholder is eligible for one Vote per share

 

The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting except in the case of interim Dividend

 

In the event of liquidation, the equity shareholders ae eligible to receive the remaining assets of the company, after distribution of all preference amounts, in proportion to their shareholding.

 

 

c) Details of shares in the company held by each shareholder holding more than 5% shares of the company

Name of Shareholder

30.06.2014

 

 

No. of Shares held

% of Holding

 

 

 

P. Vijayalakshmi

2200000

14.57%

P. Ashok Gorkey

1810000

11.99%

P. Vivek Siddarth

1800000

11.92%

P.K. Chellappan

1353206

8.96%

C.C. Paarthipan

814812

5.40%

S. Masilamani

502000

5.31%

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

 

ABRIDGED BALANCE SHEET

 

 

SOURCES OF FUNDS

 

30.06.2014

30.06.2013

30.06.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

151.100

151.100

151.100

(b) Reserves & Surplus

471.700

287.873

189.003

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

622.800

438.973

340.103

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

20.228

34.514

15.519

(b) Deferred tax liabilities (Net)

75.387

47.946

24.715

(c) Other long term liabilities

8.074

3.783

2.662

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

103.689

86.243

42.896

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.500

0.530

52.034

(b) Trade payables

274.497

223.715

203.480

(c) Other current liabilities

657.301

471.419

361.060

(d) Short-term provisions

83.302

59.259

40.613

Total Current Liabilities (4)

1015.600

754.923

657.187

 

 

 

 

TOTAL

1742.089

1280.139

1040.186

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

999.423

308.132

258.451

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

5.637

1.926

0.473

(iv) Intangible assets under development

248.691

513.075

127.909

(b) Non-current Investments

0.901

0.901

 

(c) Deferred tax assets (net)

5.394

12.881

12.378

(d)  Long-term Loan and Advances

34.936

106.551

108.251

(e) Other Non-current assets

 

 

 

Total Non-Current Assets

1294.982

943.466

507.462

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

78.052

89.192

56.168

(c) Trade receivables

0.103

5.982

72.832

(d) Cash and cash equivalents

231.722

134.528

276.126

(e) Short-term loans and advances

126.876

101.025

115.804

(f) Other current assets

10.354

5.946

11.794

Total Current Assets

447.107

336.673

532.724

 

 

 

 

TOTAL

1742.089

1280.139

1040.186

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

30.06.2014

30.06.2013

30.06.2012

 

SALES

 

 

 

 

Income

1663.980

1226.722

1076.206

 

Other Income

33.372

17.330

23.895

 

TOTAL

1697.352

1244.052

1100.101

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

246.065

306.480

311.307

 

Purchases of Stock-in-Trade

758.104

527.334

476.290

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(6.839)

(10.697)

3.858

 

Employees benefits expense

123.770

75.039

61.414

 

Other expenses

186.085

106.602

118.546

 

 Research and Development Expenses

20.800

6.576

 

 

TOTAL

1327.985

1011.334

971.415

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

369.367

232.718

128.686

 

 

 

 

 

Less

FINANCIAL EXPENSES

1.184

3.006

8.769

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

368.183

229.712

119.917

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

34.389

14.532

11.550

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

333.794

215.180

108.367

 

 

 

 

 

Less

TAX

77.440

72.115

26.516

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

256.354

143.065

81.851

 

 

 

 

 

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

34.000

15.000

8.501

 

Dividend

60.440

37.775

30.201

 

Tax on Dividend

12.084

6.420

4.904

 

Transfer from other Reserve

0.000

(0.192)

0.000

 

 Surplus at the beginning of the year

(206.751)

(121.689)

(83.462)

 

Total

(100.227)

(62.686)

(39.856)

 

 

 

 

 

 

Balance Carried to the B/S

356.581

205.751

121.707

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

16.97

9.47

5.42

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

30.06.2014

30.06.2013

30.06.2012

Current Maturities of Long term debt

11.760

11.396

1.269

Cash generated from operations

549.156

319.524

238.865

Net cash flow from operating activity

N.A

N.A

N.A

 

 

KEY RATIOS

 

 

PARTICULARS

 

 

30.06.2014

30.06.2013

30.06.2012

Net Profit Margin

(PAT / Sales)

(%)

15.41

11.66

7.61

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

22.20

18.97

11.96

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

22.53

28.64

12.05

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.54

0.49

0.32

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.05

0.11

0.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.44

0.45

0.81

 

 

STOCK PRICES

 

 

Face Value

Rs. 10.00/-

Market Value

Rs. 1284.70/-

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

 

DEBT EQUITY RATIO

 

Particular

30.06.2012

30.06.2013

30.06.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

151.100

151.100

151.100

Reserves & Surplus

189.003

287.873

471.700

Net worth

340.103

438.973

622.800

 

 

 

 

long-term borrowings

15.519

34.514

20.228

Short term borrowings

52.034

0.530

0.500

Current maturities of long-term debts

1.269

11.396

11.760

Total borrowings

68.822

46.440

32.488

Debt/Equity ratio

0.202

0.106

0.052

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

30.06.2012

30.06.2013

30.06.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1076.206

1226.722

1663.980

 

 

13.986

35.644

 

 

NET PROFIT MARGIN

 

Net Profit Margin

30.06.2012

30.06.2013

30.06.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1076.206

1226.722

1663.980

Profit

81.851

143.065

256.354

 

7.61%

11.66%

15.41%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

no

35

Negative Reporting by Auditors in the Annual Report

No

 

RESULTS OF OPERATIONS

 

India`s economic growth rate rose to 4.7% In FY2014 from 4.5% In FY2013.The Global operating environment improved considerably in FY2013-14, as economic activity strengthened.

 

 

India tops the world in exporting generic medicines worth US$ 11 billion. Currently, the Indian Pharmaceutical Industry is one of the world`s largest and most developed. Generics will continue to dominate the market while patent - protected products are likely to constitute 10 per cent of the pie till 2015, according to Mc. Kinsey report India Pharma 2015-Unlocking the potential of Indian Pharmaceuticals market`.

 

 

On Standalone basis, the Company achieved a revenue of Rs.1697.352 Million as compared to Rs.124.452 MIllion in previous year and the Standalone operating profit before finance costs, depreciation & tax was Rs.369.367 Million as compared to Rs. 232.718 Million in previous year. The Company achieved a growth of 36.43% in revenue and 58.71% in operating profit as compared to the previous year

 

 

UNAUDITED STANDALONE FINANCIAL RESULT FOR THE QUARTER ENDED 31ST MARCH, 2015

 

                                                                                                                                  (Rs. In Million)

 

 

Three Months Ended

Nine month Ended

31.03.2015

31.12.2014

31.03.2015

Unaudited

Unaudited

Unaudited

1

Income From Operations

 

 

 

 

a. Net Sales/ Income from  Operations

(Net of Excise Duty)

581.821

551.829

1661.853

 

b. Share of profit in LLP

27.352

22.784

64.892

 

Total Income from Operations (Net)

609.173

574.613

1726.745

2

Expenditure

 

 

 

 

a. Cost of material Consumed

92.857

98.399

257.298

 

 

229.995

205.644

684.406

 

b. Changes in inventory of finished Goods, work- in-progress and Stock-in-trade

(0.792)

9.142

3.466

 

c. Employees Benefit Expenses

46.341

44.265

130.267

 

d. depreciation and Amortization Expenses

13.621

18.310

50.839

 

e. Amortization of Intangible Assets

-

0.549

1.089

 

f. Foreign Exchange Fluctuation Loss

5.113

13.857

18.970

 

g. Research and Development Expenses

15.412

13.501

41.195

 

h. Other expenses

77.223

66.517

210.740

 

Total Expenses

479.440

470.184

1398.270

3

Profit from Operations before Other Income, Interest and Exceptional Items

129.733

104.429

328.475

4

Other Income

6.243

7.338

19.024

5

Profit from ordinary activities before finance cost & exceptional items

135.976

111.767

347.499

6

Finance Costs

0.390

0.454

1.318

7

Profit from ordinary activities before tax

135.586

111.313

346.181

8

Tax Expense

29.600

20.200

63.800

9

Net Profit After Tax

105.986

91.113

282.381

10

Paid-up equity share capital (face value of Rs.2 per share)

151.100

151.100

151.100

11

Earnings Per Share

-

-

-

 

Basic EPS 

7.01

6.03

18.69

 

Diluted EPS

7.01

6.03

18.69

A

PARTICULARS OF SHAREHOLDING

 

 

 

12

Public Shareholding

 

 

 

 

- No. of shares

4863247

6239247

4863247

 

- Percentage of shareholding

32.19%

41.29

32.19%

13

Promoter & Promoter Group Shareholding

 

 

 

 

a) Pledged/Encumbered

 

 

 

 

- No. of shares

-

-

-

 

- Percentage of shareholding (as a % of the total shareholding of promoter and promoter group)

-

-

-

 

- Percentage of shareholding (as a % of the total share capital of the company)

-

-

-

 

b) Non-encumbered

 

 

 

 

- No. of shares

10246753

8870753

10246753

 

- Percentage of shareholding (as a % of the total shareholding of promoter and promoter group)

100%

100%

100%

 

- Percentage of shareholding (as a % of the total share capital of the company)

67.81%

58.71%

67.81%

 

 

 

Particulars

Quarter ended 30.09.2014

B

Investor Complaints

 

 

Pending at the beginning of the quarter

--

 

Received during the quarter

46

 

Disposed off during the quarter

46

 

Remaining unresolved at the end of the quarter

-

 

Note:

1. The Company operate in one segment only

2. The above standalone unaudited financial result were considered and recommended by the Audit Committee of the Board and have  

 

 

INDEX OF CHARGES:

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10344453

31/01/2012

75,000,000.00

THE CATHOLIC SYRIAN BANK LIMITED

826 GROUND FLOOR, TARAPORE TOWERS, MOUNT ROAD BRA 
NCH, CHENNAI, TAMIL NADU - 600002, INDIA

B35868769

2

10344483

31/01/2012

125,000,000.00

THE CATHOLIC SYRIAN BANK LIMITED

826 GROUND FLOOR, TARAPORE TOWERS, MOUNT ROAD BRA 
NCH, CHENNAI, TAMIL NADU - 600002, INDIA

B35875194

3

10073263

31/01/2012 *

30,000,000.00

THE CATHOLIC SYRIAN BANK LIMITED

826, TARAPORE TOWERS, MOUNT ROAD, CHENNAI- 600002, TAMILNADU, INDIA

B35875434

4

10052661

31/01/2012 *

215,000,000.00

THE CATHOLIC SYRIAN BANK LIMITED

826 GROUND FLOOR, TARAPORE TOWERS, MOUNT ROAD BRA 
NCH, CHENNAI- 600002, TAMIL NADU, INDIA

B35874759

5

80027571

05/09/2000

8,500,000.00

CATHOLIC SYRIAN LIMITED

MOUNT ROAD,, CHENNAI, CHENNAI - 600002, TAMIL NADU, INDIA

-

6

90281799

21/01/1994

1,000,000.00

INDIAN OVERSEAS BANK

WEST MAMBALAM BRANCH, MADRAS - 600002, TAMIL NADU -
INDIA

-

 

Contingent Liabilities

Sl No

Name of the statute

Nature of dues

30.06.2014

(Rs. In Million

1

Income Tax Act, 1961

Income tax

26.110

2

Central Excise Act, 1944

Excise Duty

2.726

3

Foreign Trade (Development &

Regulation ) Act 1992

Customs Duty

-

 

FIXED ASSETS

  • Land
  • Building
  • Plant and Machinery
  • Furniture and Fixture
  • Office Equipments
  • Computer
  • Electrical Fitting
  • Motor Vehicles
  • Motor Vehicles
  • Tools and Spares
  • Lab Equipments
  • Motor Cycle

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.49

UK Pound

1

Rs.99.42

Euro

1

Rs.69.14

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUV

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

RKI


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILITY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

8

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

68

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.